Skip to main content

Table 5 System suitability testing of the chromatographic HPLC peaks

From: Chromatographic assay of recently approved co-formulation of Vonoprazan fumarate with low dose Aspirin: AGREE, Complex MoGAPI, and RGB 12-model assessments

Analyte

Retention time (Rt), min

Capacity factor (k′)

Selectivity (α)

Resolution (Rs)

Asymmetry (A)

Efficiency (plates/m)

Fumarate

1.85

2.08

1.52

4.51

0.99

3181.24

ASP

2.50

3.17

3.15

12.49

0.98

4056.96

VON

6.59

9.98

------

------

0.84

2802.89